Human Microbiome Clinical Trial
Official title:
Detection of Luminal and Mucosa-associated Microbiome in Healthy Controls vs. Local and Systemic Inflammation Under Mixed Diet
This study should reveal differences in composition of luminal and mucosa-associated microbiome of the human gastrointestinal tract.Therefore bacterial species of different intestinal location sites (small intestine and colon) isolated of biopsies were compared to bacterial composition of stool samples. Additionally the bacterial composition of healthy persons, patients with inflammatory bowel disease and with liver disease (liver cirrhosis) will be compared to detect influence of local and systemic inflammation on microbiome.
A dysbiosis of human gut microbiome is discussed in the pathogenesis of many disorders, also including gastrointestinal (e.g. inflammatory bowel disease, IBD) or liver diseases (e.g. liver cirrhosis) . A detailed analysis of intestinal bacterial patterns might reveal important findings for understanding disease pathogenesis. Thereby many studies only analysed the luminal microbiome of stool samples, whereas mucosa-associated bacteria have possibly a greater impact on human health and immune system . To determine the differences of luminal and mucosa-associated bacteria, stool and mucosa samples (via biopsies) will be collected. Thereby biopsies are taken of different intestinal locations (small intestine and colon) to detect variations along intestinal tract. An additional comparison of bacterial patterns in patients with chronic, local (IBD) and systemic inflammation (with liver cirrhosis) or without intestinal inflammations (healthy controls) should reveal the influence of microbiome on or by inflammation processes. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05560087 -
Association of PeRiODontal Disease and gUt Microbiome With Coronary artEry Disease (PRODUCE Study)
|
||
Completed |
NCT04222699 -
Cultures Before and After Decolonization in Community Dwelling Adults With Current S. Aureus Colonization
|
Phase 4 | |
Completed |
NCT02392182 -
Lung HIV Microbiome Project (Michigan Site)
|
N/A | |
Completed |
NCT04597502 -
The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties
|
N/A | |
Completed |
NCT04596722 -
Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties
|
N/A | |
Completed |
NCT02731976 -
Microbiome Composition Changes on 4 Week Gluten-free Diet Challenge
|
N/A | |
Completed |
NCT05150184 -
Isolation and Characterization of Multiple Microbial Species From Diverse Healthy Adults
|
||
Recruiting |
NCT03942159 -
Modification of the Human Colon and Oral Microbiome by Allogenic HSCT
|
||
Completed |
NCT04335526 -
A Clinical Study to Assess the Effect of Change of Bile Acid on the PD and Safety of Metformin and Microbiome Profiles
|
Phase 1 | |
Completed |
NCT03668015 -
Xylitol and Sorbitol Effects on the Oral Microbiome
|
N/A | |
Not yet recruiting |
NCT04841694 -
Oral Probiotics on the Shift in Gut Microbiome and Skin Carotenoid Levels
|
N/A | |
Enrolling by invitation |
NCT03231332 -
Effects of H.Pylori Eradication on Microbiome
|
Phase 4 | |
Completed |
NCT03181269 -
Human Milk and Infant Intestinal Microbiome Study
|
N/A | |
Completed |
NCT03543605 -
Clinical/Microbiological Impact of a Specific Antimicrobial Stewardship Program for Nursing Homes
|
N/A | |
Completed |
NCT01496898 -
Changes in Vaginal, Cervical and Uterine Microflora With Levonorgestrel Intrauterine Device Placement
|
N/A | |
Terminated |
NCT03907501 -
Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation
|
N/A | |
Completed |
NCT03809260 -
A Clinical Trial for Analysis of Intestinal Microbiome Affecting PK, PD, and Safety of Metformin
|
N/A | |
Completed |
NCT04218799 -
Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans
|
Phase 4 | |
Completed |
NCT03581812 -
Snack Foods and Their Impact on Gastrointestinal Microbiology, Function and Symptoms
|
N/A | |
Withdrawn |
NCT02407184 -
Potential Restoration of the Infant Microbiome
|
N/A |